Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure based design and in vivo reduction of amyloid β-peptides.

[1]  Jean-Michel Rondeau,et al.  Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptides. , 2012, Journal of medicinal chemistry.

[2]  A. Maguire,et al.  Copper-catalyzed asymmetric oxidation of sulfides. , 2012, The Journal of organic chemistry.

[3]  B. de Strooper,et al.  The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing , 2011, Journal of neurochemistry.

[4]  A. Vulpetti,et al.  Fluorine–Protein Interactions and 19F NMR Isotropic Chemical Shifts: An Empirical Correlation with Implications for Drug Design , 2011, ChemMedChem.

[5]  M. Citron,et al.  Alzheimer's disease: strategies for disease modification , 2010, Nature Reviews Drug Discovery.

[6]  C. Dingwall,et al.  Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics. , 2009, Bioorganic & medicinal chemistry letters.

[7]  A. Simon,et al.  In Vivo β-Secretase 1 Inhibition Leads to Brain Aβ Lowering and Increased α-Secretase Processing of Amyloid Precursor Protein without Effect on Neuregulin-1 , 2008, Journal of Pharmacology and Experimental Therapeutics.

[8]  Yu Yuan,et al.  Gold(III) catalyzed oxidation of sulfides to sulfoxides with hydrogen peroxide , 2007 .

[9]  Kazuhiro Matsumoto,et al.  Asymmetric oxidation catalysis by a chiral Al(salalen) complex: highly enantioselective oxidation of sulfides with aqueous hydrogen peroxide. , 2007, Angewandte Chemie.

[10]  P. Wong,et al.  Bace1 modulates myelination in the central and peripheral nervous system , 2006, Nature Neuroscience.

[11]  R. de Kanter,et al.  Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction , 2006, Expert opinion on drug metabolism & toxicology.

[12]  P. Saftig,et al.  Control of Peripheral Nerve Myelination by the ß-Secretase BACE1 , 2006, Science.

[13]  Rudi D'Hooge,et al.  Phenotypic and Biochemical Analyses of BACE1- and BACE2-deficient Mice* , 2005, Journal of Biological Chemistry.

[14]  C. Bolm,et al.  Investigations on the iron-catalyzed asymmetric sulfide oxidation. , 2005, Chemistry.

[15]  M. Boffito,et al.  The pharmacokinetics of HIV protease inhibitor combinations , 2005, Current opinion in infectious diseases.

[16]  R. Greenblatt,et al.  Sex differences in pharmacokinetics and pharmacodynamics. , 2004, Annual review of pharmacology and toxicology.

[17]  Stephen A. Wring,et al.  Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs , 2002, Journal of Pharmacology and Experimental Therapeutics.

[18]  I. Kola,et al.  BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. , 2001, Human molecular genetics.

[19]  D. Back,et al.  Principles and practice of HIV‐protease inhibitor pharmacoenhancement , 2001, HIV medicine.

[20]  H. Cai,et al.  BACE1 is the major β-secretase for generation of Aβ peptides by neurons , 2001, Nature Neuroscience.

[21]  W. Richards,et al.  Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation , 2001, Nature Neuroscience.

[22]  J. Tang,et al.  Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[24]  Alfredo G. Tomasselli,et al.  Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.

[25]  David G. Tew,et al.  Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.

[26]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[27]  R. Neve,et al.  Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein , 1996, The Journal of Neuroscience.

[28]  J. Hardy,et al.  Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.

[29]  G. Schellenberg,et al.  Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.

[30]  Carl R. Johnson,et al.  The Stereochemistry of Oxidation at Sulfur. Oxidation of 4-Substituted Thianes to Sulfoxides1 , 1965 .

[31]  Carl R. Johnson,et al.  Equilibration of 4-Substituted Thiane 1-Oxides , 1964 .

[32]  H. Kagan,et al.  Asymmetric oxidation of sulfides mediated by chiral titanium complexes : mechanistic and synthetic aspects , 1987 .